Skip to content

Exploration of Patient Self-medication Practices During and After Cancer in France

Exploration of Patient Self-medication Practices During and After Cancer in France: Cross-sectional Observational Study With Online Response

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05156931
Acronym
CASEME
Enrollment
681
Registered
2021-12-14
Start date
2021-12-14
Completion date
2022-04-30
Last updated
2026-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Self-medication

Keywords

cancer, self-medication, quality of life

Brief summary

The purpose of this study is to assess the patient self-medication practices during and after cancer in France, using an online questionnaire

Detailed description

Patients will be contacted by email from patient's associations. Patients will be informed of the objectives of the study and will be free to answer or not to the online questionnaire.

Interventions

None listed

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Past or active cancer

Exclusion criteria

* Speaking French * Not living in France

Design outcomes

Primary

MeasureTime frameDescription
Self-medicationday 1declaration of a practice of self-medication

Secondary

MeasureTime frameDescription
Class of products used in self-medicationday 1non-prescription medicine, herbal medicine, aromatherapy, homeopathy, and food supplements
Indication for self-medicationday 1For treatment of side-effects, improvements in anti-cancer effects
Origin of self-medication productsday 1pharmacy, market, internet, other
Perception of adverse effects and drug-drug interaction related to self medicationday 1yes / no
QLQ-C30 questionnaireday 1Global health status Functional scales Physical functioning Role functioning Emotional functioning Cognitive functioning Social functioning Fatigue Nausea and vomiting Pain Dyspnoea Insomnia Appetite loss Constipation Diarrhoea Financial difficulties

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 8, 2026